Why 89bio Stock Lagged the Market Today
Werte in diesem Artikel
89bio (NASDAQ: ETNB) couldn't quite keep pace with the broader stock market on Tuesday. Investors were hesitant to buy shares of the clinical-stage biotech, following news that it was floating a new stock issue. The company traded sideways during the session, on a day when the S&P 500 index rose by nearly 1%.Just after market close on Monday, 89bio divulged that it intends to raise as much as $287.5 million from a secondary stock issue. It will do so in an underwritten public offering of $250 million worth of its common stock, plus it aims to grant those underwriters a 30-day option to collectively purchase an additional $37.5 million. The underwriting syndicate is led by Goldman Sachs, Bank of America Securities, and Leerink Partners.Continue readingWeiter zum vollständigen Artikel bei MotleyFool
Ausgewählte Hebelprodukte auf 89bio
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf 89bio
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|
Quelle: MotleyFool
Nachrichten zu 89bio Inc Registered Shs
Analysen zu 89bio Inc Registered Shs
Keine Analysen gefunden.